Tele-Rehabilitation in Adults With Cystic Fibrosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Tele-Rehabilitation Exercise Program.
- Who it may be relevant to
- Registry conditions: Cystic Fibrosis, Sarcopenia, Frailty. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Impact of an 8-Week Tele-Rehabilitation Program on Frailty, Sarcopenia, and Quality of Life in Adults With Cystic Fibrosis
Overview
This study is a randomized controlled trial designed to evaluate the effectiveness of an 8-week tele-rehabilitation program in adults with cystic fibrosis. Cystic fibrosis is a chronic condition that affects the lungs and can lead to reduced muscle mass, physical weakness, frailty, and decreased quality of life. Participants will be randomly assigned to either a tele-rehabilitation group or a usual care group. The tele-rehabilitation program includes supervised exercise sessions conducted remotely three times per week using video communication. The program combines aerobic and resistance training based on established rehabilitation guidelines. The primary aim of the study is to assess the effect of the program
Interventions
- Behavioral Tele-Rehabilitation Exercise Program
An 8-week tele-rehabilitation program consisting of supervised aerobic and resistance exercise sessions delivered remotely three times per week using video communication. The program includes individualized exercise prescription and progressive adjustment based on participant tolerance and clinical status. Sessions are conducted by trained rehabilitation personnel following established pulmonary rehabilitation guidelines.
Primary outcome measures
- Fat-Free Mass Index (FFMI) [Time frame: Baseline to Week 8 (end of intervention)]
Secondary outcome measures (4)
- FRAIL Scale Score [Time frame: Baseline to Week 8 (end of intervention)]
- Fried Frailty Phenotype (FFP) [Time frame: Baseline to Week 8 (end of intervention)]
- Quality of Life (CFQoL) [Time frame: Baseline to Week 8 (end of intervention)]
- Physical Performance [Time frame: Baseline to Week 8 (end of intervention)]
Eligibility criteria
Inclusion criteria
- Adults aged 18 years and older
- Confirmed diagnosis of cystic fibrosis
- Clinically stable condition with no acute exacerbation at the time of enrollment
- Ability to participate in an exercise program
- Access to a device with internet connection for tele-rehabilitation sessions
- Willingness to provide informed consent
Exclusion criteria
- Acute pulmonary exacerbation within the past 4 weeks
- Severe comorbidities that limit participation in exercise (e.g., unstable cardiovascular disease)
- Musculoskeletal or neurological conditions preventing safe exercise performance
- Cognitive impairment affecting ability to follow instructions
- Participation in another structured rehabilitation or clinical trial during the study period
- Pregnancy (if applicable based on your protocol)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07500493 · CF-TR-2026-01